UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Long-acting recombinant coagulation factor IX albumin fusion protein (rIX-FP) in hemophilia B: results of a phase 3 trial

Blood, 2016-04, Vol.127 (14), p.1761-1769

2016

Volltextzugriff (PDF)

Four Decades of Carrier Detection and Prenatal Diagnosis in Hemophilia A: Historical Overview, State of the Art and Future Directions

International journal of molecular sciences, 2023-07, Vol.24 (14), p.11846

2023

Volltextzugriff (PDF)

The impact of thrombin generation and rotation thromboelastometry on assessment of severity of factor XI deficiency

Thrombosis research, 2015-08, Vol.136 (2), p.465-473

2015

Volltextzugriff (PDF)

Differential roles of fibrinogen and von Willebrand factor on clot formation and platelet adhesion in reconstituted and immune thrombocytopenia

Anesthesia and analgesia, 2011-05, Vol.112 (5), p.1034-1040

2011

Volltextzugriff (PDF)

The association between unemployment and treatment among adults with hemophilia

Research and practice in thrombosis and haemostasis, 2024-07, Vol.8 (5), p.102514, Article 102514

2024

Volltextzugriff (PDF)

Continuous infusion of coagulation factors: current opinion

Current opinion in hematology, 2006-09, Vol.13 (5), p.308-315

2006

Volltextzugriff (PDF)

Survival of hepatitis C-infected haemophilia patients is predicted by presence of cirrhosis but not by anti-viral treatment

Annals of hepatology, 2014-11, Vol.13 (6), p.753-761

2014

Volltextzugriff (PDF)

The use of fibrin tissue adhesive to reduce blood loss and the need for blood transfusion after total knee arthroplasty. A prospective, randomized, multicenter study

Journal of bone and joint surgery. American volume, 1999-11, Vol.81 (11), p.1580-8

1999

Volltextzugriff (PDF)

Phase I/II, open-label, multicenter, safety, efficacy and PK study of a recombinant coagulation factor IX albumin fusion protein (rIX-FP) in subjects with hemophilia B

Thrombosis research, 2013-03, Vol.131, p.S11-S14

2013

Volltextzugriff (PDF)

Guidelines for the use of recombinant activated factor VII (rFVIIa) in uncontrolled bleeding: a report by the Israeli Multidisciplinary rFVIIa Task Force

Journal of thrombosis and haemostasis, 2005-04, Vol.3 (4), p.640-648

2005

Volltextzugriff (PDF)

Continuous infusion of recombinant factor VIIa for surgery in patients with deficiency of factor VII

Thrombosis and haemostasis, 2005-12, Vol.94 (6), p.1177-1180

2005

Volltextzugriff (PDF)

Correction of Hemophilia as a Proof of Concept for Treatment of Monogenic Diseases by Fetal Spleen Transplantation

Proceedings of the National Academy of Sciences - PNAS, 2006-12, Vol.103 (50), p.19075-19080

2006

Volltextzugriff (PDF)

Enhancement of pig embryonic implants in factor VIII KO mice: a novel role for the coagulation cascade in organ size control

PloS one, 2009-12, Vol.4 (12), p.e8362-e8362

2009

Volltextzugriff (PDF)

Effects of increasing doses of activated recombinant factor VII on haemostatic parameters in swine

Thrombosis and haemostasis, 2005-02, Vol.93 (2), p.275-283

2005

Volltextzugriff (PDF)

Role of clinical and laboratory parameters for treatment choice in patients with inherited FVII deficiency undergoing surgical procedures: evidence from the STER registry

British journal of haematology, 2018-02, Vol.180 (4), p.563-570

2018

Volltextzugriff (PDF)

Treatment of traumatic bleeding with recombinant factor VIIa

The Lancet (British edition), 1999-11, Vol.354 (9193), p.1879-1879

1999

Volltextzugriff (PDF)

Hypertension, haematuria and renal functioning in haemophilia - a cross-sectional study in Europe

Haemophilia : the official journal of the World Federation of Hemophilia, 2016-03, Vol.22 (2), p.248-255

2016

Volltextzugriff (PDF)

Long-Term Use of Coagulation Factor IX (Recombinant) Albumin Fusion Protein (rIX-FP) in Previously Treated Patients with Hemophilia B in the Prolong-9FP Program

Blood, 2015-12, Vol.126 (23), p.1096-1096

2015

Volltextzugriff (PDF)

Single-Dose Recombinant Activated Factor VII Therapy in Hemophilia Patients With Inhibitors

Seminars in hematology, 2008-04, Vol.45 (2), p.S38-S41

2008

Volltextzugriff (PDF)

The hemostatic efficacy of chitosan-pads in hemodialysis patients with significant bleeding tendency

The journal of vascular access, 2017-05, Vol.18 (3), p.220-224

2017

Volltextzugriff (PDF)

A highly sensitive thrombin generation assay for assessment of recombinant activated factor VII therapy in haemophilia patients with an inhibitor

Thrombosis and haemostasis, 2011-04, Vol.105 (4), p.688-695

2011

Volltextzugriff (PDF)

Management of atrial fibrillation in people with haemophilia - a consensus view by the ADVANCE Working Group

Haemophilia : the official journal of the World Federation of Hemophilia, 2014-11, Vol.20 (6), p.e417-e420

2014

Volltextzugriff (PDF)

Safety and efficacy of continuous infusion of a combined factor VIII-von Willebrand factor (vWF) concentrate (Haemate-P) in patients with von Willebrand disease

Thrombosis and haemostasis, 1999, Vol.81 (2), p.229-233

1999

Volltextzugriff (PDF)

Efficacy and safety of prophylaxis with once-weekly BAY 79-4980 compared with thrice-weekly rFVIII-FS in haemophilia A patients. A randomised, active-controlled, double-blind study

Thrombosis and haemostasis, 2012-11, Vol.108 (5), p.913-922

2012

Volltextzugriff (PDF)

Updates in the management of severe coagulopathy in trauma patients

Intensive care medicine, 2002-10, Vol.28 Suppl 2, p.S241-s247

2002

Volltextzugriff (PDF)

1 – 25 von 116

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(90)
Mit Volltextzugriff
(91)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Long-acting recombinant coagulation factor IX albumin fusion protein (rIX-FP) in hemophilia B: results of a phase 3 trial

Four Decades of Carrier Detection and Prenatal Diagnosis in Hemophilia A: Historical Overview, State of the Art and Future Directions

The impact of thrombin generation and rotation thromboelastometry on assessment of severity of factor XI deficiency

Differential roles of fibrinogen and von Willebrand factor on clot formation and platelet adhesion in reconstituted and immune thrombocytopenia

The association between unemployment and treatment among adults with hemophilia

Continuous infusion of coagulation factors: current opinion

Survival of hepatitis C-infected haemophilia patients is predicted by presence of cirrhosis but not by anti-viral treatment

The use of fibrin tissue adhesive to reduce blood loss and the need for blood transfusion after total knee arthroplasty. A prospective, randomized, multicenter study

Phase I/II, open-label, multicenter, safety, efficacy and PK study of a recombinant coagulation factor IX albumin fusion protein (rIX-FP) in subjects with hemophilia B

Guidelines for the use of recombinant activated factor VII (rFVIIa) in uncontrolled bleeding: a report by the Israeli Multidisciplinary rFVIIa Task Force

Continuous infusion of recombinant factor VIIa for surgery in patients with deficiency of factor VII

Correction of Hemophilia as a Proof of Concept for Treatment of Monogenic Diseases by Fetal Spleen Transplantation

Enhancement of pig embryonic implants in factor VIII KO mice: a novel role for the coagulation cascade in organ size control

Effects of increasing doses of activated recombinant factor VII on haemostatic parameters in swine

Role of clinical and laboratory parameters for treatment choice in patients with inherited FVII deficiency undergoing surgical procedures: evidence from the STER registry

Treatment of traumatic bleeding with recombinant factor VIIa

Hypertension, haematuria and renal functioning in haemophilia - a cross-sectional study in Europe

Long-Term Use of Coagulation Factor IX (Recombinant) Albumin Fusion Protein (rIX-FP) in Previously Treated Patients with Hemophilia B in the Prolong-9FP Program

Single-Dose Recombinant Activated Factor VII Therapy in Hemophilia Patients With Inhibitors

The hemostatic efficacy of chitosan-pads in hemodialysis patients with significant bleeding tendency

A highly sensitive thrombin generation assay for assessment of recombinant activated factor VII therapy in haemophilia patients with an inhibitor

Management of atrial fibrillation in people with haemophilia - a consensus view by the ADVANCE Working Group

Safety and efficacy of continuous infusion of a combined factor VIII-von Willebrand factor (vWF) concentrate (Haemate-P) in patients with von Willebrand disease

Efficacy and safety of prophylaxis with once-weekly BAY 79-4980 compared with thrice-weekly rFVIII-FS in haemophilia A patients. A randomised, active-controlled, double-blind study

Updates in the management of severe coagulopathy in trauma patients

Suchergebnisse filtern